Tagged with A

Argentine Ministry of Science ¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón del desarrollo económico y social de esos mismos países. El ministerio en Argentina se creó en ese sentido, para ayudar a transformar el conocimiento…

Baxter Germany Next year Baxter will accomplish its 50th anniversary in Germany. In the context of its celebration, what would you highlight as the main achievements of the company especially since you took the reigns of the German operations? Baxter Germany has grown steadily in the German market primarily thanks to its…

G-BA In the last twenty years, Germany has experienced nearly twenty health care reforms. In your opinion, what have been the main reasons for so many changes? The main reason behind two decades of continuous health care reforms is the persistent federal budget restraint. This ultimately meant that an increased number…

Acropolis Associates Could you provide us with an introduction to the company as well as your operations in Shanghai, New York or Singapore? I created Acropolis Associates ten years ago in New York, along with two friends that I met during an Executive MBA program. We entered China in 2004 with operations…

Ministry of Health Indonesia Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is your assessment on how government policy is contributing toward improved health care in terms of current policies and priorities? Indonesia’s…

Janssen-Cilag Argentina When we spoke to Javier Lombar of IMS Argentina, he explained that a lot of multinational companies use Argentina as a base for regional operations. How does Janssen-Cilag operate in this Latin American context, and what role does the Argentinean operation play in Janssen-Cilag’s plans? Janssen-Cilag sees the pharmaceutical business…

Korea Research based Pharmaceutical Industry Since KRPIA’s creation in 1999, what would you say have been its main achievements in the South Korean pharmaceutical landscape? KRPIA’s foremost achievement during its existence has been its contribution to bringing the focus on R&D to the pharmaceutical industry in South Korea. Our member companies spend between 17% and…

Ferring Italy After long experience in the pharmaceutical industry, working in both multinational and local laboratories, you took the reins of the already well-established Italian subsidiary of Ferring a few months ago. To what extent did your previous experiences help you to bring a new perspective to Ferring Italy? My professional path…

IMS Health Italy You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical market? The Italian situation is changing a lot, at a different speed than in other countries. For years, Italians had…

Roche Italy Roche Italy is one of the companies which went through the most significant re-organization process in the country in the past three years- with important changes in both its marketing and industrial strategies. As you leaded the company through this period, could you expose the actions you took and the…

ProGenerika The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do generics play in the German pharmaceutical market and how have they managed to achieve such a wide penetration? Generics play…

CAEMe Through your work as member of the Council of the IFPMA, as well as FIFARMA, and CAEMe, you must have a very developed and unique perspective on the characteristics of the Argentinean and International pharmaceutical markets. Can you explain the importance of Argentina within the Latin American framework? One important…